Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2016-03, Vol.172 (6), p.983-986
Hauptverfasser: Viola, Shelton, Traer, Elie, Huan, Jianya, Hornick, Noah I., Tyner, Jeffrey W., Agarwal, Anupriya, Loriaux, Marc, Johnstone, Brian, Kurre, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 986
container_issue 6
container_start_page 983
container_title British journal of haematology
container_volume 172
creator Viola, Shelton
Traer, Elie
Huan, Jianya
Hornick, Noah I.
Tyner, Jeffrey W.
Agarwal, Anupriya
Loriaux, Marc
Johnstone, Brian
Kurre, Peter
description
doi_str_mv 10.1111/bjh.13551
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4755922</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1772146970</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4851-c4ca4fa0902424a3dc8ed7da5bd665aae13df2b172586f2d5b1dc24c507dcb853</originalsourceid><addsrcrecordid>eNp1kcFuFSEUhonR2Gt14QsYlrq4LTDDMHdj0jZqNU3c6JqcgTO9tAxUYLzeZ-hLlzq10YUsIDl8-TiHn5DXnB3xuo6Hq-0Rb6TkT8iKN51cC97yp2TFGFNrztr-gLzI-Yox3jDJn5MD0bGNVEKtyO2JL5iguBgydYGCmQvSaY8-Oks9zteAkwM6xFDLkFLc0VxSnMBTg95T_BVznJCaGAqGUk8XjLNId65s6SW4xVv2KWZXHdcuQMZa2rrBlZhowuxygWDwJXk2gs_46uE8JN8_fvh2dr6--Prp89nJxdq0veR1N9COwDZMtKKFxpoerbIgB9t1EgB5Y0cxcCVk343CyoFbI1ojmbJm6GVzSN4v3pt5mNCa2nYCr2-SqwPudQSn_70Jbqsv40_dKik3QlTB2wdBij9mzEVPLt__BgSMc9ZcqZpAt1Gsou8W1NT5c8Lx8RnO9H14uoanf4dX2Td_9_VI_kmrAscLsHMe9_836dMv54vyDqZsqPg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1772146970</pqid></control><display><type>article</type><title>Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><source>Wiley Online Library Free Content</source><creator>Viola, Shelton ; Traer, Elie ; Huan, Jianya ; Hornick, Noah I. ; Tyner, Jeffrey W. ; Agarwal, Anupriya ; Loriaux, Marc ; Johnstone, Brian ; Kurre, Peter</creator><creatorcontrib>Viola, Shelton ; Traer, Elie ; Huan, Jianya ; Hornick, Noah I. ; Tyner, Jeffrey W. ; Agarwal, Anupriya ; Loriaux, Marc ; Johnstone, Brian ; Kurre, Peter</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.13551</identifier><identifier>PMID: 26095727</identifier><language>eng</language><publisher>England</publisher><subject>acute myeloid leukaemia ; Adolescent ; Adult ; Aged ; Antineoplastic Agents - therapeutic use ; chemo‐resistance ; Child ; Drug Resistance, Neoplasm ; exosomes ; Exosomes - pathology ; Female ; Humans ; Leukemia, Myeloid, Acute - pathology ; Male ; Mesenchymal Stromal Cells - pathology ; microRNA ; Middle Aged ; Protein Kinase Inhibitors - therapeutic use ; Protein-Tyrosine Kinases - antagonists &amp; inhibitors ; stroma ; Young Adult</subject><ispartof>British journal of haematology, 2016-03, Vol.172 (6), p.983-986</ispartof><rights>2015 John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4851-c4ca4fa0902424a3dc8ed7da5bd665aae13df2b172586f2d5b1dc24c507dcb853</citedby><cites>FETCH-LOGICAL-c4851-c4ca4fa0902424a3dc8ed7da5bd665aae13df2b172586f2d5b1dc24c507dcb853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.13551$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.13551$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26095727$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Viola, Shelton</creatorcontrib><creatorcontrib>Traer, Elie</creatorcontrib><creatorcontrib>Huan, Jianya</creatorcontrib><creatorcontrib>Hornick, Noah I.</creatorcontrib><creatorcontrib>Tyner, Jeffrey W.</creatorcontrib><creatorcontrib>Agarwal, Anupriya</creatorcontrib><creatorcontrib>Loriaux, Marc</creatorcontrib><creatorcontrib>Johnstone, Brian</creatorcontrib><creatorcontrib>Kurre, Peter</creatorcontrib><title>Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><subject>acute myeloid leukaemia</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>chemo‐resistance</subject><subject>Child</subject><subject>Drug Resistance, Neoplasm</subject><subject>exosomes</subject><subject>Exosomes - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Leukemia, Myeloid, Acute - pathology</subject><subject>Male</subject><subject>Mesenchymal Stromal Cells - pathology</subject><subject>microRNA</subject><subject>Middle Aged</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</subject><subject>stroma</subject><subject>Young Adult</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcFuFSEUhonR2Gt14QsYlrq4LTDDMHdj0jZqNU3c6JqcgTO9tAxUYLzeZ-hLlzq10YUsIDl8-TiHn5DXnB3xuo6Hq-0Rb6TkT8iKN51cC97yp2TFGFNrztr-gLzI-Yox3jDJn5MD0bGNVEKtyO2JL5iguBgydYGCmQvSaY8-Oks9zteAkwM6xFDLkFLc0VxSnMBTg95T_BVznJCaGAqGUk8XjLNId65s6SW4xVv2KWZXHdcuQMZa2rrBlZhowuxygWDwJXk2gs_46uE8JN8_fvh2dr6--Prp89nJxdq0veR1N9COwDZMtKKFxpoerbIgB9t1EgB5Y0cxcCVk343CyoFbI1ojmbJm6GVzSN4v3pt5mNCa2nYCr2-SqwPudQSn_70Jbqsv40_dKik3QlTB2wdBij9mzEVPLt__BgSMc9ZcqZpAt1Gsou8W1NT5c8Lx8RnO9H14uoanf4dX2Td_9_VI_kmrAscLsHMe9_836dMv54vyDqZsqPg</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Viola, Shelton</creator><creator>Traer, Elie</creator><creator>Huan, Jianya</creator><creator>Hornick, Noah I.</creator><creator>Tyner, Jeffrey W.</creator><creator>Agarwal, Anupriya</creator><creator>Loriaux, Marc</creator><creator>Johnstone, Brian</creator><creator>Kurre, Peter</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201603</creationdate><title>Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance</title><author>Viola, Shelton ; Traer, Elie ; Huan, Jianya ; Hornick, Noah I. ; Tyner, Jeffrey W. ; Agarwal, Anupriya ; Loriaux, Marc ; Johnstone, Brian ; Kurre, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4851-c4ca4fa0902424a3dc8ed7da5bd665aae13df2b172586f2d5b1dc24c507dcb853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>acute myeloid leukaemia</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>chemo‐resistance</topic><topic>Child</topic><topic>Drug Resistance, Neoplasm</topic><topic>exosomes</topic><topic>Exosomes - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Leukemia, Myeloid, Acute - pathology</topic><topic>Male</topic><topic>Mesenchymal Stromal Cells - pathology</topic><topic>microRNA</topic><topic>Middle Aged</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</topic><topic>stroma</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Viola, Shelton</creatorcontrib><creatorcontrib>Traer, Elie</creatorcontrib><creatorcontrib>Huan, Jianya</creatorcontrib><creatorcontrib>Hornick, Noah I.</creatorcontrib><creatorcontrib>Tyner, Jeffrey W.</creatorcontrib><creatorcontrib>Agarwal, Anupriya</creatorcontrib><creatorcontrib>Loriaux, Marc</creatorcontrib><creatorcontrib>Johnstone, Brian</creatorcontrib><creatorcontrib>Kurre, Peter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Viola, Shelton</au><au>Traer, Elie</au><au>Huan, Jianya</au><au>Hornick, Noah I.</au><au>Tyner, Jeffrey W.</au><au>Agarwal, Anupriya</au><au>Loriaux, Marc</au><au>Johnstone, Brian</au><au>Kurre, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2016-03</date><risdate>2016</risdate><volume>172</volume><issue>6</issue><spage>983</spage><epage>986</epage><pages>983-986</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><cop>England</cop><pmid>26095727</pmid><doi>10.1111/bjh.13551</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2016-03, Vol.172 (6), p.983-986
issn 0007-1048
1365-2141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4755922
source Wiley-Blackwell Journals; MEDLINE; Wiley Online Library Free Content
subjects acute myeloid leukaemia
Adolescent
Adult
Aged
Antineoplastic Agents - therapeutic use
chemo‐resistance
Child
Drug Resistance, Neoplasm
exosomes
Exosomes - pathology
Female
Humans
Leukemia, Myeloid, Acute - pathology
Male
Mesenchymal Stromal Cells - pathology
microRNA
Middle Aged
Protein Kinase Inhibitors - therapeutic use
Protein-Tyrosine Kinases - antagonists & inhibitors
stroma
Young Adult
title Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T23%3A27%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alterations%20in%20acute%20myeloid%20leukaemia%20bone%20marrow%20stromal%20cell%20exosome%20content%20coincide%20with%20gains%20in%20tyrosine%20kinase%20inhibitor%20resistance&rft.jtitle=British%20journal%20of%20haematology&rft.au=Viola,%20Shelton&rft.date=2016-03&rft.volume=172&rft.issue=6&rft.spage=983&rft.epage=986&rft.pages=983-986&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.13551&rft_dat=%3Cproquest_pubme%3E1772146970%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1772146970&rft_id=info:pmid/26095727&rfr_iscdi=true